|
May 10
|
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Amicus Therapeutics Inc (FOLD) Q1 2024 Earnings: Surpasses Revenue Estimates and Projects ...
|
|
May 10
|
Amicus (FOLD) Q1 Earnings Top, Sales Lag, '24 Outlook Updated
|
|
May 10
|
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
May 9
|
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 9
|
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
|
|
May 8
|
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference
|
|
May 3
|
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
|
|
May 1
|
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
|
|
May 1
|
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
|
|
Apr 19
|
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
|
|
Mar 29
|
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
|
|
Mar 20
|
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
|
|
Mar 13
|
13 Best Biotech Stocks To Buy Under $20
|
|
Mar 7
|
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)
|
|
Mar 5
|
Amicus Therapeutics Stock Sees RS Rating Improve To 74
|
|
Jan 12
|
Amicus (FOLD) Stock Rises More Than 25% in 3 Months: Here's Why
|
|
Jan 8
|
Amicus (FOLD) Issues Preliminary Revenue Results for FY23
|
|
Jan 7
|
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
|
|
Jan 6
|
Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 15,833 Shares
|